Epidemiology of soy exposures and breast cancer risk.

Wu AH, Yu MC, Tseng CC, Pike MC. · 2008

Read Epidemiology of soy exposures and breast cancer risk. by Wu AH, Yu MC, Tseng CC, Pike MC. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2359677.txt.

Introduction

Wu and colleagues reviewed soy foods and breast cancer risk in 2008. Soy contains isoflavones, plant compounds that act weakly like the hormone estrogen. Because estrogen itself can drive breast cancer, researchers had long debated whether soy protects or harms.

The authors focused on studies that measured soy intake well and adjusted for other risk factors. In eight studies of Asian women, who eat much soy, risk fell steadily as intake rose. Women eating the most soy, at least 20 milligrams of isoflavones a day, had an odds ratio of 0.71, and mid-level intake sat between that and the low group. In eleven Western studies, intake was far lower and no link appeared. They concluded Asian-level soy intake may protect against breast cancer.

Catalog record

CREATORWu AH, Yu MC, Tseng CC, Pike MC.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2359677

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Epidemiology of soy exposures and breast cancer risk By A H Wu, M C Yu, C-C Tseng, M C Pike Published in: British Journal of Cancer DOI: 10.1038/sj.bjc.6604145 ABSTRACT Abstract Most of the early studies published on soy and breast cancer were not designed to test the effect of soy; the assessment of soy intake was usually crude and few potential confounders were considered in the analysis. In this review, we focused on studies with relatively complete assessment of dietary soy exposure in the targeted populations and appropriate consideration for potential confounders in the statistical analysis of study data. Meta-analysis of the 8 (1 cohort, 7 case–control) studies conducted in high-soy-consuming Asians show a significant trend of decreasing risk with increasing soy food intake. Compared to the lowest level of soy food intake (⩽5 mg isoflavones per day), risk was intermediate (OR=0.88, 95% confidence interval (CI)=0.78–0.98) among those with modest (∼10 mg isoflavones per day) intake and lowest (OR=0.71, 95% CI=0.60–0.85) among those with high intake (⩾20 mg isoflavones per day). In contrast, soy intake was unrelated to breast cancer risk in studies conducted in the 11 low-soy-consuming Western populations whose average highest and lowest soy isoflavone intake levels were around 0.8 and 0.15 mg per day, respectively. Thus, the evidence to date, based largely on case–control studies, suggest that soy food intake in the amount consumed in Asian populations may have protective effects against breast cancer. Keywords: soy, Asian and Western populations, breast cancer Soybeans and its products have been a staple in the Asian diet for centuries. Soybeans are the predominant source of isoflavones, one of the three main classes of phytoestrogens or plant oestrogens. Genistein and daidzein are the two major isoflavones; glycitein is a minor component. These soy isoflavone compounds are structurally similar to 17-β estradiol but possess weaker oestrogenic potencies. Given the recognised aetiologic association between oestrogen and breast cancer risk, there is biological plausibility that dietary soy intake may have anti-carcinogenic effect on the breast. A favoured mechanism by which soy isoflavones may influence breast cancer development is via their affinity and competition with endogenous oestrogens and other substrates in binding with oestrogen receptors (ERs). It has also been suggested that soy isoflavones may influence breast cancer risk via their anti-proliferative, anti-angiogenic, anti-oxidative and anti-inflammatory properties (Gilani and Anderson, 2002). Lee et al (1991) first reported a reduced risk of breast cancer in premenopausal Singapore Chinese women who were high consumers of soy. Since then, there has been tremendous interest in the possible role of soy in the prevention of breast cancer. However, there is also the concern that soy may have stimulatory effects on the breast. Dietary genistein and highly processed soy agents have been found to stimulate growth in the MCF-7 breast cancer cells, and to promote breast cancer in ovaraectomised athymic mice models (for a review, see Messina et al, 2006). In a short term soy-feeding trial, women randomised to the soy arm exhibited significantly higher indices of increased DNA synthesis relative to women in the control arm, although this apparent association failed to persist following the inclusion of 33 additional subjects (Hargreaves et al, 1999). The questions we would like to address in this review are as follows: (1) What is the epidemiologic evidence on soy and breast cancer? Is there a dose–response relationship? (2) Does the endogenous oestrogen environment, as reflected by menopausal status and body weight, affect this association? (3) Does timing of soy exposure affect this association? (4) Does the type of soy ingested affect this association, given that it can be consumed in the form of soy products that are common in a typical Asian diet or as fillers/extenders in processed foods? We identified a total of 28 epidemiologic studies in English language with sufficiently detailed information on soy and breast cancer risk. Fourteen studies were included in the meta-analysis by Trock et al (2006). Of the remaining 14 studies, 6 were conducted in Asia (Hirose et al, 2005; Lee et al, 2005; Shannon et al, 2005; Ho et al, 2006; Do et al, 2007; Nishio et al, 2007) while the rest were conducted in various Western populations (Peterson et al, 2003; dos Santos Silva et al, 2004; Keinan-Boker et al, 2004; Bosetti et al, 2005; Thanos et al, 2006; Touillaud et al, 2006; Fink et al, 2007; Verheus et al, 2007). Given that Asians differ from Western populations in terms of types and amounts of soy consumed, and possess distinct characteristics linked to breast cancer risk, we conducted separate meta-analysis on epidemiologic data derived from Asians and Western populations, respectively. RISK ASSOCIATION STUDIES IN HIGH-SOY-CONSUMING ASIANS In Asia, soy food is consumed traditionally as nonfermented soy foods (tofu, sometimes known as bean curd, soybeans and soy milk), fermented soy foods (miso and natto) or other soy products (fried, dried and pressed soy products), and the average intake is between 25 and 50 mg of isoflavones per day (Messina et al, 2006). In contrast, intake of soy isoflavones in Western populations is usually less than 1.0 mg of isoflavones per day and Asian soy foods are rarely consumed. Their sources of soy isoflavones come from some legumes, sprouts and vegetables containing small amounts of isoflavones, and from soy flour and soy protein that are commonly added as extenders and fillers in different bakery and canned goods (Horn-Ross et al, 2001). Eight of the 14 studies conducted in Asia or in Asian Americans captured the main sources of soy intake and carefully adjusted for relevant dietary and non-dietary potential confounders. We excluded the remaining six (two cohort, four case–control) studies from the meta-analysis due to incomplete assessment of soy intake in those studies. Specifically, two studies (Wu et al, 1996; Ho et al, 2006) examined only about intake of tofu. Four other studies (Yuan et al, 1995; Key et al, 1999; Hirose et al, 2003; Nishio et al, 2007) asked about intake of several soy foods that captured between 40 and 60% of total soy intake in those populations. In the eight (one cohort, seven case–control) studies with relatively complete assessment of total soy intake, dietary soy exposure was expressed in varying units, including grams of soy foods per day (Lee et al, 1991, 2005; Hirose et al, 2005; Shannon et al, 2005; Do et al, 2007), grams of soy protein per day (Lee et al, 1991; Dai et al, 2001), and milligrams of soy isoflavones per day (Wu et al, 2002; Yamamoto et al, 2003; Hirose et al, 2005). To facilitate comparison between individual studies, all dietary soy exposures were converted to units of milligram of isoflavones assuming that 1 g of soy protein or 10 g of soy food contain 3 mg of isoflavones (Messina et al, 2006; Trock et al, 2006). Table 1 shows the meta-analysis of these eight studies with information on total soy food intake and breast cancer in Asian women. There was a statistically significant 29% reduction in the risk of breast cancer associated with high soy intake (summary OR=0.71, 95% confidence interval (CI)=0.60–0.85) compared to the lowest level of soy intake (Table 1). Results of the individual studies are shown in Figure 1A. Across these Asian studies, the median cut

Read the complete text